Hepatitis
Clinical Review
Open Clinical Trials for Patients With HIV and/or Hepatitis B and C
The primary objective of this study is to implement and evaluate a web-based brief alcohol intervention (BAI) for treating veterans with hepatitis...
Conference Coverage
CKD triples risk of bad outcomes in HIV
BOSTON – Smoking, diabetes, dyslipidemia, low body mass index, and poor HIV control were modifiable risk factors for CKD.
News
HCV Patient on Tacrolimus? Keep an Eye on RBCs
Recent case caused clinicians to reevaluate monitoring red blood cells when interpreting tacrolimus levels in patients with HCV.
Conference Coverage
How to choose between highly effective HBV therapies
The newest drug, tenofovir alafenamide, has the edge in its safety profile for treating chronic hepatitis B infection.
Article
Interferon-α Treatment and Depression
New research may highlight a correlation between a common HCV treatment and the development of mental health conditions.
Conference Coverage
Hep B therapy: Indefinite or FINITE for e-negative patients?
LAS VEGAS –
News
Antiviral Treatment May Not Matter to Mother-Child HBV Transmission
Recent National Institutes of Health (NIH) research proves administering tenofovir disoproxil fumarate before and after pregnancy has little...
Conference Coverage
MicroRNAs flag liver damage in HIV-, HCV-infected persons
MicroRNAs are associated with elevated liver enzymes and fibrosis in HIV, HCV infection.
News
HIV+ dialysis patients: Differential survival by race compared with HIV/HCV coinfection
HIV infection, but not HIV/HCV coinfection, associated with differential dialysis survival according to race.
News
HCV infection tied to premature ovarian senescence and a high miscarriage rate
Infertility and adverse pregnancy outcomes in HCV-infected women appear associated with increased ovarian senescence.